A xenograft nude mouse model for perineural invasion and recurrence in pancreatic cancer

被引:38
作者
Eibl, G [1 ]
Reber, HA [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Hirshberg Pancreat Canc Lab, Div Gen Surg, Los Angeles, CA 90095 USA
关键词
animal model; pancreatic cancer; perineural invasion; recurrence;
D O I
10.1097/01.mpa.0000175176.40045.0f
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: Pancreatic cancer recurrence after initially "curative'' resection is an unresolved clinical problem in the management of patients with this disease. Perineural invasion correlates with and might be partially responsible for tumor recurrence and poor survival. However, no adequate preclinical animal model is yet available to study this aspect of pancreatic cancer biology. Methods: We modified our orthotopic xenograft model of pancreatic cancer in nude mice to develop a model for pancreatic cancer perineural invasion and recurrence. Results: After initial orthotopic transplantation, complete surgical resection of MIA PaCa-2 ( undifferentiated) and Capan-2 ( well-differentiated) tumors at 4, 6, and 8 weeks was attempted. All animals that had undergone tumor resection survived the operation. Animals that had the MIA PaCa-2 tumor resected after 6 weeks developed recurrent pancreatic cancer with local invasion and distant metastasis. Histological evaluation revealed extensive invasion of retroperitoneal nerves by the cancer cells. Conclusion: Complete resection of orthotopically transplanted pancreatic cancer in nude mice leads to local tumor recurrence. This model may eventually prove valuable for studying the mechanisms of pancreatic cancer perineural invasion and recurrence.
引用
收藏
页码:258 / 262
页数:5
相关论文
共 31 条
[1]   Current standards of surgery for pancreatic cancer [J].
Alexakis, N ;
Halloran, C ;
Raraty, M ;
Ghaneh, P ;
Sutton, R ;
Neoptolemos, JP .
BRITISH JOURNAL OF SURGERY, 2004, 91 (11) :1410-1427
[2]  
Bales E, 2005, CANCER RES, V65, P692
[3]  
BOSLAND MC, 1990, CANCER RES, V50, P700
[4]   Therapy for pancreatic cancer with a recombinant humanized anti-HER2 antibody (herceptin) [J].
Büchler, P ;
Reber, HA ;
Büchler, MC ;
Roth, MA ;
Büchler, MW ;
Friess, H ;
Isacoff, WH ;
Hines, OJ .
JOURNAL OF GASTROINTESTINAL SURGERY, 2001, 5 (02) :139-146
[5]   Prevention of metastatic pancreatic cancer growth in vivo by induction of apoptosis with genistein, a naturally occurring isoflavonoid [J].
Büchler, P ;
Gukovskaya, TS ;
Mouria, T ;
Büchler, MC ;
Büchler, MW ;
Friess, H ;
Pandol, TJ ;
Reber, HA ;
Hines, OJ .
PANCREAS, 2003, 26 (03) :264-273
[6]   Orthotopic murine model of head and neck squamous cell carcinoma [J].
Cabanillas, R. ;
Secades, P. ;
Rodrigo, J. P. ;
Astudillo, A. ;
Suarez, C. ;
Chiara, M. D. .
ACTA OTORRINOLARINGOLOGICA ESPANOLA, 2005, 56 (03) :89-95
[7]   Orthotopic models of human pancreatic cancer [J].
Capellá, G ;
Farré, L ;
Villanueva, A ;
Reyes, G ;
García, C ;
Tarafa, G ;
Lluís, F .
CELL AND MOLECULAR BIOLOGY OF PANCREATIC CARCINOMA: RECENT DEVELOPMENTS IN RESEARCH AND EXPERIMENTAL THERAPY, 1999, 880 :103-109
[8]  
Eibl G, 2005, CANCER RES, V65, P982
[9]   Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse [J].
Hingorani, SR ;
Petricoin, EF ;
Maitra, A ;
Rajapakse, V ;
King, C ;
Jacobetz, MA ;
Ross, S ;
Conrads, TP ;
Veenstra, TD ;
Hitt, BA ;
Kawaguchi, Y ;
Johann, D ;
Liotta, LA ;
Crawford, HC ;
Putt, ME ;
Jacks, T ;
Wright, CVE ;
Hruban, RH ;
Lowy, AM ;
Tuveson, DA .
CANCER CELL, 2003, 4 (06) :437-450
[10]   Perineural invasion in pancreatic cancer [J].
Hirai, I ;
Kimura, W ;
Ozawa, K ;
Kudo, S ;
Suto, K ;
Kuzu, H ;
Fuse, A .
PANCREAS, 2002, 24 (01) :15-25